Sjlee: 새 문서: # Korea Centers for Disease Control and Prevention. 2009년 성병관리지침. 2009. # 성기단순포진#cite ref-Report from a Korea Centers for Disease Control and Prevention 2...

2019-07-01T01:29:34Z

새 문서: # Korea Centers for Disease Control and Prevention. 2009년 성병관리지침. 2009. # 성기단순포진#cite ref-Report from a Korea Centers for Disease Control and Prevention 2...

새 문서

# Korea Centers for Disease Control and Prevention. 2009년 성병관리지침. 2009.
# [[성기단순포진#cite ref-Report from a Korea Centers for Disease Control and Prevention 2007 2-0|이동↑]] Lee JK. Report from a Korea Centers for Disease Control and Prevention 2007. KCDC, 2008;98:127-30.
# [[성기단순포진#cite ref-.EB.B0.94.EC.9D.B4.EB.9F.AC.EC.8A.A4.EC.84.B1 .EC.84.B1.EB.B3.91 .EC.9C.A0.EB.B3.91.EB.A5.A0 .EB.B0.8F .EC.97.AD.ED.95.99.EC.A0.81 .ED.8A.B9.EC.84.B1 .EC.97.B0.EA.B5.AC 3-0|이동↑]] 이승주, 조용현. 바이러스성 성병 유병률 및 역학적 특성 연구. 질병관리본부; 2009.
# [[성기단순포진#cite ref-.EB.B6.80.EC.82.B0.EC.A7.80.EC.97.AD .EB.B0.94.EC.9D.B4.EB.9F.AC.EC.8A.A4.EC.84.B1 .EC.84.B1.EB.B3.91 .EA.B0.90.EC.97.BC.EC.96.91.EC.83.81 .EC.97.B0.EA.B5.AC. 4-0|이동↑]] 조경순, 나영란, 조현철, 이정희, 정명주. 부산지역 바이러스성 성병 감염양상 연구. 미생물학회지 2006;42(3):177-184.
# [[성기단순포진#cite ref-Seroprevalence of human herpes simplex virus-2 in Jeollanam-do. 5-0|이동↑]] Song HJ, Jeon DY, Shin MY, Park SS, Kim CM, Heo NC. Seroprevalence of human herpes simplex virus-2 in Jeollanam-do. 2005.
# [[성기단순포진#cite ref-Incidence of herpes simplex virus type 2 infection in the United States 6-0|이동↑]] Armstrong GL, Schillinger J, Markowitz L, et al. Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol 2001;153:912-920.
# [[성기단순포진#cite ref-Antenatal seroprevalence of Herpes simplex virus type 2 .28HSV-2.29 in Canadian women: HSV-2 prevalence increases throughout the reproductive years. 7-0|이동↑]] Patrick DM, Dawar M, Cook DA, Krajden M, Ng HC, Rekart ML. Antenatal seroprevalence of Herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout the reproductive years. Sex Transm Dis 2001;28:424- 428.
# [[성기단순포진#cite ref-Herpes simplex virus seroprevalence and risk factors in 2 Canadian sexually transmitted disease clinics. 8-0|이동↑]] Singh AE, Romanowski B, Wong T, et al. Herpes simplex virus seroprevalence and risk factors in 2 Canadian sexually transmitted disease clinics. Sex Transm Dis 2005;32:95- 100.
# [[성기단순포진#cite ref-Predominance of herpes simplex virus type 1 from patients with genital herpes in Nova Scotia. 9-0|이동↑]] Forward KR, Lee SHS. Predominance of herpes simplex virus type 1 from patients with genital herpes in Nova Scotia. Can J Infect Dis 2003;14:94-96.
# [[성기단순포진#cite ref-Once-daily valacyclovir to reduce the risk of transmission of genital herpes. 10-0|이동↑]] Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004;350:11-20.
# ↑ [[성기단순포진#cite ref-Risk factors for the sexual transmission of genital herpes. 11-0|이동:11.0]] [[성기단순포진#cite ref-Risk factors for the sexual transmission of genital herpes. 11-1|11.1]] [[성기단순포진#cite ref-Risk factors for the sexual transmission of genital herpes. 11-2|11.2]] [[성기단순포진#cite ref-Risk factors for the sexual transmission of genital herpes. 11-3|11.3]] Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992;116:197-202.
# [[성기단순포진#cite ref-Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. 12-0|이동↑]] Bryson Y, Dillon M, Bernstein DI, Radolf J, Zakowski P, Garratty E. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis 1993;167:942-946.
# ↑ [[성기단순포진#cite ref-Genital herpes simplex virus infections: clinical manifestations.2C course.2C and complications. 13-0|이동:13.0]] [[성기단순포진#cite ref-Genital herpes simplex virus infections: clinical manifestations.2C course.2C and complications. 13-1|13.1]] [[성기단순포진#cite ref-Genital herpes simplex virus infections: clinical manifestations.2C course.2C and complications. 13-2|13.2]] [[성기단순포진#cite ref-Genital herpes simplex virus infections: clinical manifestations.2C course.2C and complications. 13-3|13.3]] Corey L, Adams HG, Brown ZA, et al. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983;98:958-972.
# ↑ [[성기단순포진#cite ref-The Truth about Herpes 14-0|이동:14.0]] [[성기단순포진#cite ref-The Truth about Herpes 14-1|14.1]] Sacks SL. The Truth about Herpes. 4th ed. Vancouver, BC: Gordon Soule Book Publishers: 1997.
# [[성기단순포진#cite ref-Recurrences after oral and genital herpes simplex virus infection. 15-0|이동↑]] Lafferty WE, Coombs RW, Benedetti J, et al. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med 1987;316:1444-1449.
# [[성기단순포진#cite ref-Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time 16-0|이동↑]] Benedetti JK, Zeh J, Corey L. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med 1999;131:14-20.
# ↑ [[성기단순포진#cite ref-Reactivation of genital herpes simplex type 2 infection in asymptomatic seropositive persons. 17-0|이동:17.0]] [[성기단순포진#cite ref-Reactivation of genital herpes simplex type 2 infection in asymptomatic seropositive persons. 17-1|17.1]] [[성기단순포진#cite ref-Reactivation of genital herpes simplex type 2 infection in asymptomatic seropositive persons. 17-2|17.2]] [[성기단순포진#cite ref-Reactivation of genital herpes simplex type 2 infection in asymptomatic seropositive persons. 17-3|17.3]] [[성기단순포진#cite ref-Reactivation of genital herpes simplex type 2 infection in asymptomatic seropositive persons. 17-4|17.4]] Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000;342:844-850.
# ↑ [[성기단순포진#cite ref-Genital shedding of herpes simplex virus among men. 18-0|이동:18.0]] [[성기단순포진#cite ref-Genital shedding of herpes simplex virus among men. 18-1|18.1]] [[성기단순포진#cite ref-Genital shedding of herpes simplex virus among men. 18-2|18.2]] [[성기단순포진#cite ref-Genital shedding of herpes simplex virus among men. 18-3|18.3]] Wald A, Zeh J, Selke S, et al. Genital shedding of herpes simplex virus among men. J Infect Dis 2002;186(suppl 1):S34-S39.
# ↑ [[성기단순포진#cite ref-Virologic characteristics of subclinical and symptomatic genital herpes infections. 19-0|이동:19.0]] [[성기단순포진#cite ref-Virologic characteristics of subclinical and symptomatic genital herpes infections. 19-1|19.1]] [[성기단순포진#cite ref-Virologic characteristics of subclinical and symptomatic genital herpes infections. 19-2|19.2]] Wald A, Zeh J, Selke S, et al. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995;333:770-775.
# ↑ [[성기단순포진#cite ref-Genital herpes simplex virus infections: current concepts in diagnosis.2C therapy and prevention. 20-0|이동:20.0]] [[성기단순포진#cite ref-Genital herpes simplex virus infections: current concepts in diagnosis.2C therapy and prevention. 20-1|20.1]] [[성기단순포진#cite ref-Genital herpes simplex virus infections: current concepts in diagnosis.2C therapy and prevention. 20-2|20.2]] Corey L, Holmes KK. Genital herpes simplex virus infections: current concepts in diagnosis, therapy and prevention. Ann Intern Med 1983;98:973-983.
# [[성기단순포진#cite ref-The Tzanck smear in the diagnosis of cutaneous herpes simplex. 21-0|이동↑]] Soloman AR, Rasmussen JE, Varani J, et al. The Tzanck smear in the diagnosis of cutaneous herpes simplex. JAMA 1984;251:633-635.
# [[성기단순포진#cite ref-Immunity to herpesvirus infections in humans. 22-0|이동↑]] Lopez C, Arvin AM, Ashley R. Immunity to herpesvirus infections in humans. In: Roizman B, Whitley RJ, Lopez C, eds. The Human Herpesviruses. New York, NY: Raven Press; 1993.
# [[성기단순포진#cite ref-Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection. 23-0|이동↑]] Ashley RL, Eagleton M, Pfeiffer N. Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection. J Clin Microbiol 1999;37:1632-1633.
# [[성기단순포진#cite ref-Progress and pitfalls in serological testing for genital herpes 24-0|이동↑]] Ashley RL. Progress and pitfalls in serological testing for genital herpes. Herpes 1994;1:49-51.
# [[성기단순포진#cite ref-Kinetics of human antibody responses to primary genital herpes simplex virus infection. 25-0|이동↑]] Kohl S, Adam E, Matson DO, Kaufman RH, Dreesman GR. Kinetics of human antibody responses to primary genital herpes simplex virus infection. Intervirology 1982;18:164- 168.
# ↑ [[성기단순포진#cite ref-Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. 26-0|이동:26.0]] [[성기단순포진#cite ref-Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. 26-1|26.1]] [[성기단순포진#cite ref-Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. 26-2|26.2]] Mertz GJ, Critchlow CW, Benedetti J, et al. Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection. JAMA 1984;252:1147- 1151.
# [[성기단순포진#cite ref-Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: four approved indications and 13 off-label uses. 27-0|이동↑]] Aoki FY. Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: four approved indications and 13 off-label uses. Can J Infect Dis. 2003;14:17-27.
# [[성기단순포진#cite ref-Patients.E2.80.99 preference of valacyclovir once-daily suppressive therapy versus twice-daily episodic therapy for recurrent genital herpes: a randomized study. 28-0|이동↑]] Romanowski B, Marina RB, Roberts JN, Valtrex HS230017 Study Group. Patients’ preference of valacyclovir once-daily suppressive therapy versus twice-daily episodic therapy for recurrent genital herpes: a randomized study. Sex Transm Dis 2003;30:226- 231.
# [[성기단순포진#cite ref-Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection. 29-0|이동↑]] Patel R, Tyring S, Strand A, et al. Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection. Sex Transm Infect 1999;75:398-402.
# [[성기단순포진#cite ref-Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. 30-0|이동↑]] Wald AM, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001;285:3100-3106.
# [[성기단순포진#cite ref-Management of genital infections in pregnant women. 31-0|이동↑]] Donders GG. Management of genital infections in pregnant women. Curr Opin Infect Dis 2006;19:55-61.
# [[성기단순포진#cite ref-Management of sexually transmitted disease during pregnancy. 32-0|이동↑]] Park JS. Management of sexually transmitted disease during pregnancy. J Korean Med Assoc 2008;51:897-904.
# [[성기단순포진#cite ref-Characteristics of recurrent genital herpes simplex infections in pregnant women. 33-0|이동↑]] Harger JH, Amortegui AJ, Meyer MP, Pazin GJ. Characteristics of recurrent genital herpes simplex infections in pregnant women. Obstet Gynecol 1989;73:367-372.
# [[성기단순포진#cite ref-Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. 34-0|이동↑]] Nagot N, Ouédraogo A, Foulongne V, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007;356:790-799.
# [[성기단순포진#cite ref-Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. 35-0|이동↑]] Brown ZA, Wald A, Morrow RA, et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003;289:203- 209.
# [[성기단순포진#cite ref-The acquisition of herpes simplex virus during pregnancy. 36-0|이동↑]] Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-515.
# ↑ [[성기단순포진#cite ref-Natural history of neonatal herpes simplex virus infections in the acyclovir era. 37-0|이동:37.0]] [[성기단순포진#cite ref-Natural history of neonatal herpes simplex virus infections in the acyclovir era. 37-1|37.1]] [[성기단순포진#cite ref-Natural history of neonatal herpes simplex virus infections in the acyclovir era. 37-2|37.2]] Kimberlin DW, Lin CY, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001;108:223-229.
# ↑ [[성기단순포진#cite ref-Neonatal herpes simplex virus infection: a report of 43 patients. 38-0|이동:38.0]] [[성기단순포진#cite ref-Neonatal herpes simplex virus infection: a report of 43 patients. 38-1|38.1]] [[성기단순포진#cite ref-Neonatal herpes simplex virus infection: a report of 43 patients. 38-2|38.2]] Koskiniemi M, Happonen JM, Jarvenpaa AL, Pettay O, Vaheri A. Neonatal herpes simplex virus infection: a report of 43 patients. Pediatr Infect Dis 1989;8:30-35.
# ↑ [[성기단순포진#cite ref-Changing presentation of herpes simplex virus infection in neonates. 39-0|이동:39.0]] [[성기단순포진#cite ref-Changing presentation of herpes simplex virus infection in neonates. 39-1|39.1]] Whitley RJ, Corey L, Arvin A, et al. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis 1988;158:109-116.
# [[성기단순포진#cite ref-Paediatric Surveillance Program .28CPSP.29. Epidemiology of neonatal herpes simplex virus infections in Canada. 40-0|이동↑]] Kropp RY, Wong T, Cormier L, Ringrose A, Embree J, Steben M, Canadian Paediatric Surveillance Program (CPSP). Epidemiology of neonatal herpes simplex virus infections in Canada. Presented at the International Society for STD Research (ISSTDR) conference 2005, Amsterdam.

참고문헌 성기단순포진 - 편집 역사

Sjlee: 새 문서: # Korea Centers for Disease Control and Prevention. 2009년 성병관리지침. 2009. # 성기단순포진#cite ref-Report from a Korea Centers for Disease Control and Prevention 2...